“Procter & Gamble has agreed to acquire Merck KGaA’s consumer health unit for 3.4 billion euros ($4.2 billion), giving it vitamin brands such as Seven Seas and greater exposure to Latin American and Asian markets,” reported CNBC. The transaction involved the acquisition of Merck Limited, a listed Indian company, through Procter & Gamble Overseas India B.V, including 3,300 Merck employees. A mandatory tender offer to minority shareholders will be made for the Indian entity.

Cyril Amarchand Mangaldas advised The Procter & Gamble Company led by a team of managing partner Cyril Shroff, and partners Anchal Dhir, Ravi Kumar, Bharat Budholia, SR Patnaik and Ashwin Sapra, as well as partners Sandeep Dave and Ranjan Negi.

Freshfields Bruckhaus Deringer advised Merck KGaA.

Jones Day was also involved.

Update 29 May 2019: Platinum Partners advised Merck led by a team of partner Ankit Majmudar, partner Sunandan Majmudar, associate Shriti Shah, associate Aayush Kumar, associate Unnati Divecha.

Primary jurisdiction of deal: Germany.

2018-04-19

Deal value: USD 4.2 billion

This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.